Ramp or Brex for a Multi-Hospital Veterinary Group

A group purchasing agreement negotiated centrally is worthless if individual hospitals keep ordering from whichever distributor rep shows up that week, because the volume the agreement was based on never actually consolidates. The fix isn't a policy memo, it's making sure every hospital's vendor spend rolls up into one view that someone actually looks at, so a pattern of hospitals defaulting to different distributors for the same product gets caught and corrected.

Ramp's category and vendor-level controls let you set an approved distributor list that applies consistently across every hospital's card, rather than leaving vendor choice to whoever is placing the order that day. If your group has already negotiated better terms with one distributor, Ramp helps enforce that choice at the point of purchase instead of hoping practice managers remember to use it.

A hospital that needs to place a same-day order for a controlled substance shortage or an unusual case's medication needs a card limit high enough to clear that purchase without a manual approval delay, and Brex's limits, scaling with the group's cash position, tend to handle that better than a flat per-card cap sized for routine reorders. If drug order urgency is rare in your group, this matters less than the standardization question above.

The instinct when centralizing purchasing is to add an approval step before any order clears, which is exactly the wrong move for a hospital that needs medication same-day for a patient in front of them. Instead, let approved-vendor purchases clear automatically and route only unapproved-vendor purchases for review, so the controls catch the pattern you actually care about (drift away from negotiated terms) without slowing down the orders that can't wait.

Before going back to a distributor to renegotiate group terms, pull at least a full quarter of consolidated spend across every hospital on that vendor, broken out by product line, not just a total dollar figure. A distributor negotiating against a vague volume claim will discount less than one negotiating against a specific, verified purchase history, and that history is only available once hospital spend is actually visible in one place rather than scattered across separate statements. Keep that report on a recurring quarterly cadence even after the first renegotiation closes, since distributor pricing drifts over time and a group that only checks in once loses its negotiating position within a year or two.

Prepare these inputs before you go back to a distributor:

• Pull at least a full quarter of consolidated spend across every hospital for the distributor you plan to renegotiate with.
• Break that spend out by product line, not just a total dollar figure, so the distributor sees a specific and verified purchase history.
• Check which hospitals bought the same product from a different distributor, since that gap shows where group volume isn't consolidating.
• Build the approved vendor list around product categories, so a specialty or emergency hospital can still order what its case mix requires.

Once cross-hospital vendor spend is visible, resist the temptation to compare hospitals purely on total spend or spend per patient visit without accounting for case mix. A hospital doing more emergency and specialty work will naturally run higher pharmaceutical and supply costs than one focused on routine wellness visits, and treating that difference as inefficiency rather than case mix leads to the wrong conversation with the wrong hospital manager. Segment comparisons by service type before flagging an outlier, the same way you would before questioning a manager's judgment on any other metric.

The most common failure after centralizing vendor choice is a practice manager continuing to order from a familiar rep out of habit, not defiance, simply because the switch to an approved vendor list wasn't communicated clearly enough at rollout. The purchase still clears if category restrictions are loose during the transition period, and a month later nobody remembers to tighten them or check whether hospitals actually shifted their ordering.

Set a specific date, thirty days after rollout, to pull a report comparing each hospital's actual vendor usage against the approved list, and follow up directly with any hospital still showing significant spend outside it. A cross-hospital purchasing agreement only pays off once ordering behavior actually reflects it, not once the policy is announced.